Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults

NCT07144527 is registered in ClinicalTrials.gov with Scott Silveira as lead sponsor.

NCT NCT07144527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07144527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
Lead sponsor
Scott Silveira
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2026
Completion date
January 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, exercise tolerance, frailty, healthy male and female subjects